A PYMNTS Company
Antitrust Chronicle<sup>®</sup> – Healthcare

Antitrust Chronicle® – Healthcare

Spring 2020, Volume 2, Number 1

Dear Readers, In this Chronicle we turn to the timely issue of healthcare and competition. In light of the COVID-19 pandemic, the healthcare industry, in all its facets, including the development of pharmaceuticals, the provision of healthcare, and health insurance, has never been as vital. Antitrust rules have a key…

Read More

In this issue

Antitrust Chronicle® – Healthcare
CPI
May 11, 2020
Potential and Nascent Competition in FTC Merger Enforcement in Health Care Markets
Mike Moiseyev
May 11, 2020
Price Transparency: Friend or Foe? How Price Transparency May Impact Competition in the Health Care Industry
Dionne Lomax
May 11, 2020
Antitrust & COVID-19 in The U.S.: Four Key Issues for Healthcare Providers
John Carroll
May 11, 2020
Pay-For-Delay: Who Does the Generic Industry Lobby Represent?
Michael Carrier
May 11, 2020
Economic Tools for Analyzing Vertical Mergers in Healthcare
Josh Lustig
May 11, 2020
Non-Compete Agreements: Might They be Procompetitive in Healthcare?
Paul Wong
May 11, 2020
First of All, Do No Harm: New Directions in EU Antitrust Enforcement Regarding Pharmaceuticals
Ilan Akker
May 11, 2020
Rethinking Pharmaceutical Product Reformulations
Amalia Athanasiadou
May 11, 2020

In case you missed it...



January
See more Chronicles by year:

Featured News

UK Business Secretary Calls for More Agile Competition Regulator
Feb 13, 2025 by

Germany’s Antitrust Regulator Raises Concerns Over Apple’s App Tracking Policies
Feb 13, 2025 by

$60 Billion Nissan-Honda Merger Falls Apart
Feb 13, 2025 by

DOJ Moves to End Protections for Three Regulatory Agencies
Feb 13, 2025 by

Meta to Allow Rivals to List Ads on Facebook Marketplace Following EU Fine
Feb 13, 2025 by